NCT07236580 Buteyko Breathing and Approach of Smoking Hygiene: Effects on Dysfucntion of Eustachian Tube and Lung Functions
| NCT ID | NCT07236580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Tobacco Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-09-15 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
adolescents are usually exposed to tobacco smoke passively. this can reduce their lung functions and negatively impact functions of Eustachian tube. The solution is to lower rates to tobacco exposure and use the support of Buteyko Breathing
Eligibility Criteria
Inclusion Criteria: * Dysfucntion of Eustachian Tube (obstructive chronic form) * adolescents with passive tobacco exposure from smoking parent or household member * adolscent participants whose parents approve the participation Exclusion Criteria: * cardiac problem * chest disease * renal/hepatic disease
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07236580 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Tobacco Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07236580 currently recruiting?
Yes, NCT07236580 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07236580 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07236580 clinical trial?
NCT07236580 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.